Home Cart 0 Sign in  
X

[ CAS No. 4815-28-5 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 4815-28-5
Chemical Structure| 4815-28-5
Chemical Structure| 4815-28-5
Structure of 4815-28-5 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 4815-28-5 ]

Related Doc. of [ 4815-28-5 ]

Alternatived Products of [ 4815-28-5 ]

Product Details of [ 4815-28-5 ]

CAS No. :4815-28-5 MDL No. :MFCD00111277
Formula : C9H12N2OS Boiling Point : -
Linear Structure Formula :- InChI Key :FFAKFORHXDNYEN-UHFFFAOYSA-N
M.W : 196.27 Pubchem ID :290223
Synonyms :

Calculated chemistry of [ 4815-28-5 ]

Physicochemical Properties

Num. heavy atoms : 13
Num. arom. heavy atoms : 5
Fraction Csp3 : 0.44
Num. rotatable bonds : 1
Num. H-bond acceptors : 1.0
Num. H-bond donors : 2.0
Molar Refractivity : 54.25
TPSA : 97.35 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : Yes
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.14 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.51
Log Po/w (XLOGP3) : 1.91
Log Po/w (WLOGP) : 1.32
Log Po/w (MLOGP) : 0.88
Log Po/w (SILICOS-IT) : 2.37
Consensus Log Po/w : 1.6

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.48
Solubility : 0.652 mg/ml ; 0.00332 mol/l
Class : Soluble
Log S (Ali) : -3.58
Solubility : 0.0519 mg/ml ; 0.000265 mol/l
Class : Soluble
Log S (SILICOS-IT) : -2.01
Solubility : 1.91 mg/ml ; 0.00975 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 1.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.54

Safety of [ 4815-28-5 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P280 UN#:N/A
Hazard Statements:H302-H312-H332 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 4815-28-5 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 4815-28-5 ]
  • Downstream synthetic route of [ 4815-28-5 ]

[ 4815-28-5 ] Synthesis Path-Upstream   1~6

  • 1
  • [ 108-94-1 ]
  • [ 107-91-5 ]
  • [ 4815-28-5 ]
YieldReaction ConditionsOperation in experiment
90% With morpholine; sulfur In ethanol at 20℃; for 6 h; To the stirred solution of Compound 1 (3.0 g, 30.56 mmol), 2-cyanoacetamide (2.56 g, 30.56 mmol), sulfur powder (0.97 g,30.56 mmol) in ethanol (40 mL) was added morpholine (5.31 mL,61.11 mmol) and stirred the reaction mixture at room temperature for 6 h. The reaction mixture was concentrated, diluted with EtOAc and washed the organic layer with H2O (2x30 mL). The separated organic layer was dried over anhydrous Na2SO4, evaporated and purified by column chromatography to get Compound 2 (5.40 g,90percent) as an light yellow solid. ESI-MS found 197 [M+H]+.
79% With morpholine; sulfur In ethanol at 50℃; for 5 h; Compound 2: 2-amino-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxamide Cyclohexanone (Compound 1,10 mL),morpholine (2 mL), elemental sulfur (3.2 g), and cyanoacetamide(8.4 g) were added to absolute ethanol (80 mL).The reaction mixture was refluxed at 50 °C for 5 h. After cooling, a yellow solid was filtered, washed with absolute ethanol, and dried at 40 °C under an infrared lamp to give Compound 2 in a yield of 79percent.
78% at 20 - 58℃; To a stirred mixture of cyanoacetamide (1a; 10 g) and cyclohexanone(2a; 12.3 g), at room temperature, Sulfur was added (3a;4.139 g). Upon addition of diethylamine (11.8 ml) an exothermic reaction started and the temperature rose to 55-58 °C for 1 h. The reaction mixture was stirred at 45-50 °C for 1 h and left overnightat room temperature. The solid obtained was filtered, washed withchilled ethanol and dried. 4.1.1.1. 3-Amino-4,5,6,7-tetrahydrobenzo[b]thiophene-2-carboxamide (4a). 78percent yield; M.P.178 °C; IR (KBr) ν(cm-1): 3390,3155, 2941,1660, 1560; 1H NMR (400 MHz, DMSO-d6):δ (ppm) 6.90(br s, 2H, NH2), 6.32 (br s, 2H, NH2), 2.59e2.62 (m, 2H, CyclohexylCH2), 2.46e2.48 (m, 2H, Cyclohexyl CH2), 1.70e1.77 (m, 4H, CyclohexylCH2); LC-MS/MS (M+H)+: 197.0 (calculated 196.07); Elemental analysis (percent): Calculated (Found) for C9H12N2OS: C 55.08(55.01), H 6.16 (6.19), N 14.27 (14.31), S 16.34 (16.40).
68% With morpholine; sulfur In ethanol for 4 h; Reflux General procedure: Cyclohexanone (for 18a), 1-benzoylpiperidin-3-one (for 18b) or 1-benzoylpiperidin-4-one (for 18c) (0.42mmol), cyanoacetamide (34mg, 0.40mmol) and sulfur (16mg, 0.50mmol) were suspended in EtOH (1mL). To this was added morpholine (70mg, 0.80mmol). The resulting mixture was refluxed gently with stirring for 4h, and was allowed to cool to room temperature. Solvent was removed and the residue was purified by flash chromatography on silica gel using hexanes:EtOAc (1:2) to give compounds 18a-c as off white powder.
49.6% With sulfur; diethylamine In ethanol at 40 - 50℃; for 5 h; In a 250 mL three-necked flask, 10.1 g (120 mmol) of cyanoacetamide, 3.8 g (120 mmol) of elemental sulfur,11.8 g (120 mmol) of cyclohexanone and 38 mL of absolute ethanol,8.8 g (5.0 mmol) of diethylamine was slowly added dropwise to the above mixture at a temperature of 40 to 50 ° C and stirred for 5 h. The crystals were cooled and filtered to give a brownish solid which was washed twice with a small amount of anhydrous ethanol. To give 11.7 g of a yellow solid powder in a yield of 49.6percent.
4.8% With morpholine; sulfur In ethanol at 20 - 55℃; for 22 h; General procedure: A mixture of the ketone (1 eq.), cyanoacetate (1 eq.), and elemental sulphur (1eq.) in ethanol were combined and heated at 40-70 °C. Morpholine or diethylamne (1 eq.) was added dropwise. The reaction was stirred at 40-70 °C for 1-4 hours, and then stirred at room temperature overnight. The resulting precipitate was typically collected by filtration and recrystallised from ethanol or toluene.

Reference: [1] Bioorganic and Medicinal Chemistry, 2016, vol. 24, # 21, p. 5556 - 5564
[2] Journal of Medicinal Chemistry, 2014, vol. 57, # 10, p. 4337 - 4350
[3] Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 2005, vol. 44, # 11, p. 2367 - 2371
[4] Medicinal Chemistry, 2017, vol. 13, # 8, p. 753 - 760
[5] European Journal of Medicinal Chemistry, 2017, vol. 138, p. 1053 - 1065
[6] Synthetic Communications, 2005, vol. 35, # 10, p. 1351 - 1357
[7] European Journal of Medicinal Chemistry, 2019, p. 179 - 192
[8] Mendeleev Communications, 2012, vol. 22, # 1, p. 15 - 17
[9] European Journal of Medicinal Chemistry, 2010, vol. 45, # 1, p. 69 - 77
[10] Journal of Medicinal Chemistry, 2013, vol. 56, # 13, p. 5436 - 5445
[11] Patent: CN105061462, 2017, B, . Location in patent: Paragraph 0017-0018; 0021-0023
[12] Tetrahedron, 2006, vol. 62, # 29, p. 7121 - 7131
[13] Bioorganic and Medicinal Chemistry Letters, 2011, vol. 21, # 23, p. 7089 - 7093
[14] Bioorganic and Medicinal Chemistry Letters, 2005, vol. 15, # 16, p. 3763 - 3766
[15] Bioorganic and Medicinal Chemistry Letters, 2005, vol. 15, # 21, p. 4731 - 4735
[16] Bioorganic and Medicinal Chemistry, 2009, vol. 17, # 14, p. 5336 - 5341
[17] Bioorganic and Medicinal Chemistry Letters, 2010, vol. 20, # 19, p. 5753 - 5756
[18] Molecules, 2012, vol. 17, # 6, p. 7217 - 7231
[19] Letters in Organic Chemistry, 2014, vol. 11, # 5, p. 380 - 385
[20] Bioorganic and Medicinal Chemistry Letters, 2015, vol. 25, # 6, p. 1306 - 1309
[21] Bioorganic and Medicinal Chemistry Letters, 2017, vol. 27, # 18, p. 4462 - 4466
[22] European Journal of Medicinal Chemistry, 2018, vol. 143, p. 568 - 576
[23] Chemical Biology and Drug Design, 2018, vol. 91, # 6, p. 1141 - 1155
[24] Main Group Metal Chemistry, 2018, vol. 41, # 1-2, p. 21 - 26
  • 2
  • [ 4651-91-6 ]
  • [ 4815-28-5 ]
YieldReaction ConditionsOperation in experiment
70% at 20℃; for 65 h; A solution of aminothiophene EO (prepared as described in Example C; 500mg, 2.8 mmol) in concentrated sulphuric acid (5ml) was stirred at room temperature for 65 hours. The reaction mixture was poured cautiously into ice-cold aqueous potassium carbonate, diluted with water and extracted with ethyl acetate. The combined organic extracts were washed with water and brine, dried over magnesium sulphate and evaporated to dryness under reduced pressure to give the desired product (383mg, 70percent) as an off-white solid. 'H NMR 8H (400MHz, CDC13) : 6.15 (2H, br s), 4.40 (2H, b-r s), 2. 65 (2H, m), 2.50 (2H, m) and 1.80 (4H, m) ppm.
Reference: [1] Archiv der Pharmazie, 1981, vol. 314, # 2, p. 168 - 175
[2] Patent: WO2005/44008, 2005, A2, . Location in patent: Page/Page column 105-106
[3] Chemical and Pharmaceutical Bulletin, 2015, vol. 63, # 6, p. 450 - 456
  • 3
  • [ 107-91-5 ]
  • [ 4815-28-5 ]
YieldReaction ConditionsOperation in experiment
50% With sulfur In methanol at 20℃; Reflux General procedure: Tert-butyl cyanoacetate (10 mmol), prepared according to known procedure [6] was heated to reflux with TEA (30 mmol), sulphur (10 mmol) and freshly distilled cyclohexane (10 mmol) in 15 ml of methanol for 5 h and stirred in RT overnight. The solvent was rotatory evaporated and the residue was dissolved in chloroform and filtrated. The organic layer was washed with 0.1 M solution of hydrochloric acid and distilled water. The organic layer was dried over anhydrous Na2SO4 and evaporated. The residue was purified by column chromatography (n-hexane: chloroform). Yield 72 percent as dark yellow oil that solidifies under vacuum.The reaction was carried out as for tert-butyl 2-amino-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylate. Purification by column chromatography (chloroform: ethyl acetate) Yield 50percent as yellow crystals. mp 185-188 °C. IR (ATR): 3398, 3299, 3183, 2928, 2832, 1626, 1558, 1480, 1418 cm-1. 1H NMR (300 MHz, CDCl3) δ 5.56 (s, 2H), 5.42-4.81 (wm, 2H), 2.69-2.59 (m, 2H), 2.59-2.48 (m, 2H) 1.85-1.77 (m,4H).13C NMR (75 MHz, CDCl3) δ 168.6, 160.8, 129.2, 118.8, 107.7, 77.4, 27.2, 24.7, 23.1.
Reference: [1] European Journal of Medicinal Chemistry, 2018, vol. 150, p. 261 - 267
  • 4
  • [ 5634-51-5 ]
  • [ 108-94-1 ]
  • [ 4815-28-5 ]
Reference: [1] Patent: WO2008/117269, 2008, A2, . Location in patent: Page/Page column 47
  • 5
  • [ 704-16-5 ]
  • [ 4815-28-5 ]
Reference: [1] European Journal of Medicinal Chemistry, 2010, vol. 45, # 9, p. 4365 - 4369
[2] Patent: CN107253944, 2017, A, . Location in patent: Paragraph 0044; 0045; 0046
  • 6
  • [ 108-94-1 ]
  • [ 4815-28-5 ]
Reference: [1] Patent: CN107253944, 2017, A,
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 4815-28-5 ]

Amides

Chemical Structure| 51486-03-4

[ 51486-03-4 ]

2-Amino-5-methylthiophene-3-carboxamide

Similarity: 0.85

Chemical Structure| 18593-44-7

[ 18593-44-7 ]

5,6-Dimethylthieno[2,3-d]pyrimidin-4(3H)-one

Similarity: 0.73

Chemical Structure| 14080-51-4

[ 14080-51-4 ]

2-Aminothiophene-3-carboxamide

Similarity: 0.71

Chemical Structure| 108831-66-9

[ 108831-66-9 ]

6-Methyl-3H-thieno[2,3-d]pyrimidin-4-one

Similarity: 0.68

Chemical Structure| 371206-03-0

[ 371206-03-0 ]

2-(4-Oxo-4,5,6,7-tetrahydro-3H-cyclopenta[4,5]thieno[2,3-d]pyrimidin-3-yl)acetic acid

Similarity: 0.68

Amines

Chemical Structure| 51486-03-4

[ 51486-03-4 ]

2-Amino-5-methylthiophene-3-carboxamide

Similarity: 0.85

Chemical Structure| 5936-58-3

[ 5936-58-3 ]

2-Amino-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylic acid

Similarity: 0.73

Chemical Structure| 14080-51-4

[ 14080-51-4 ]

2-Aminothiophene-3-carboxamide

Similarity: 0.71

Chemical Structure| 1216924-54-7

[ 1216924-54-7 ]

4,5,6,7-Tetrahydrobenzo[b]thiophen-2-amine oxalate

Similarity: 0.68

Chemical Structure| 61627-58-5

[ 61627-58-5 ]

N-(3-Cyano-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl)propionamide

Similarity: 0.67

Related Parent Nucleus of
[ 4815-28-5 ]

Other Aromatic Heterocycles

Chemical Structure| 5936-58-3

[ 5936-58-3 ]

2-Amino-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylic acid

Similarity: 0.73

Chemical Structure| 18593-44-7

[ 18593-44-7 ]

5,6-Dimethylthieno[2,3-d]pyrimidin-4(3H)-one

Similarity: 0.73

Chemical Structure| 108831-66-9

[ 108831-66-9 ]

6-Methyl-3H-thieno[2,3-d]pyrimidin-4-one

Similarity: 0.68

Chemical Structure| 371206-03-0

[ 371206-03-0 ]

2-(4-Oxo-4,5,6,7-tetrahydro-3H-cyclopenta[4,5]thieno[2,3-d]pyrimidin-3-yl)acetic acid

Similarity: 0.68

Chemical Structure| 1216924-54-7

[ 1216924-54-7 ]

4,5,6,7-Tetrahydrobenzo[b]thiophen-2-amine oxalate

Similarity: 0.68